Published in J Clin Microbiol on January 01, 1983
Historical perspectives and identification of Neisseria and related species. Clin Microbiol Rev (1988) 2.05
Use of the API NeIdent system for identification of pathogenic Neisseria spp. and Branhamella catarrhalis. J Clin Microbiol (1984) 1.18
Epidemiology of PPNG infections in the Netherlands: analysis by auxanographic typing and plasmid identification. Br J Vener Dis (1984) 1.09
Urethritis caused by novel Neisseria meningitidis serogroup W in man who has sex with men, Japan. Emerg Infect Dis (2014) 0.98
Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men. PLoS One (2016) 0.93
Relation between nutritional requirements and susceptibilities to antibiotics of strains of Neisseria gonorrhoeae from pharyngeal and anogenital sites. Genitourin Med (1985) 0.77
Comparison of Neisseria gonorrhoeae isolates from homosexual and heterosexual men. Genitourin Med (1985) 0.77
Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen. Proc Natl Acad Sci U S A (2017) 0.75
Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92
Characteristics of atypical Neisseria gonorrhoeae from disseminated and localized infections. Infect Immun (1976) 3.08
Isolation of Neisseria meningitidis from the Genito-urinary tract and anal canal. J Clin Microbiol (1975) 2.76
Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun (1982) 2.55
Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science (1977) 2.37
Bacteriocin production by strains of Neisseria meningitidis. J Bacteriol (1966) 2.30
Conjugal transfer of the gonococcal penicillinase plasmid. Science (1977) 2.22
Isolation of Chlamydia trachomatis from throat and rectum of homosexual men. Br J Vener Dis (1977) 1.54
In-vitro and in-vivo studies of resistance to rifampin in meningococci. J Infect Dis (1971) 1.46
Neisseria meningitidis urethritis. A case report. JAMA (1979) 1.44
Correlation of auxotype and penicillin susceptibility of Neisseria gonorrhoeae with sexual preference and clinical manifestations of gonorrhea. Sex Transm Dis (1980) 1.41
Anogenital infection with Neisseria meningitidis in homosexual men. J Infect Dis (1978) 1.27
Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens. JAMA (1980) 1.25
Prevalence and site-pathogen studies of Neisseria meningitidis and N gonorrhoeae in homosexual men. JAMA (1980) 1.18
Infections in children due to Neisseria meningitidis serogroup 135. J Pediatr (1978) 1.10
Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro. Appl Microbiol (1970) 1.06
Neisseria meningitidis serogroup W 135 disease in adults. JAMA (1981) 0.98
Meningitis caused by Neisseria meningitidis type W-135. J Pediatr (1978) 0.88
Meningitis caused by Neisseria meningitidis serogroup 135. J Clin Microbiol (1978) 0.87
Isolation of N. meningitidis from patients in a gonorrhea screen program: a four-year survey in New York City. Am J Public Health (1981) 0.83
Nonsymptomatic urethral gonorrhea in homosexual men. Sex Transm Dis (1981) 0.80
Replacement of a phosphoenolpyruvate-dependent phosphotransferase by a nicotinamide adenine dinucleotide-linked dehydrogenase for the utilization of mannitol. J Bacteriol (1967) 9.88
Development of Streptomycin-resistant Variants of Meningococcus. Science (1947) 5.80
Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis (1986) 4.92
Sodium polyanethol sulfonate sensitivity of anaerobic cocci. Appl Microbiol (1974) 4.65
Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol (1993) 4.12
Simplified radioenzymatic assay for chloramphenicol. Antimicrob Agents Chemother (1978) 3.96
New medium for blood cultures. Appl Microbiol (1969) 3.40
Two Streptomycin-resistant Variants of Meningococcus. J Bacteriol (1947) 3.36
Community-acquired pneumonia. Lancet (1998) 3.21
Characteristics of atypical Neisseria gonorrhoeae from disseminated and localized infections. Infect Immun (1976) 3.08
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis (1990) 2.44
Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 2.13
Plasmid deoxyribonucleic acid in clinical isolates of Neisseria gonorrhoeae. J Bacteriol (1975) 2.11
Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med (1977) 2.08
Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. Biochemistry (1992) 1.96
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother (1999) 1.90
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
Rapid detection and identification of enteric bacteria from blood cultures. J Infect Dis (1975) 1.83
API QuadFERM+ with rapid DNase for identification of Neisseria spp. and Branhamella catarrhalis. J Clin Microbiol (1987) 1.77
Evaluation of the RIM-N, Gonochek II, and Phadebact systems for the identification of pathogenic Neisseria spp. and Branhamella catarrhalis. J Clin Microbiol (1985) 1.68
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation. J Clin Microbiol (1982) 1.68
A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother (1997) 1.63
Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob Agents Chemother (1995) 1.54
Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli. Antimicrob Agents Chemother (1979) 1.51
Regulation and extracellular glucosyltransferase production and the relationship between extracellular and cell-associated activities in Streptococcus mutans. Infect Immun (1976) 1.50
Clinical evaluation of the Vitek ANI card for identification of anaerobic bacteria. J Clin Microbiol (1988) 1.46
Negative images of mycobacteria in aspiration biopsy smears from the lymph node of a patient with acquired immunodeficiency syndrome (AIDS): report of a case and a review of the literature. Diagn Cytopathol (1993) 1.44
Direct susceptibility testing of blood culture isolates with the AutoMicrobic System (AMS). Diagn Microbiol Infect Dis (1987) 1.43
The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis (1997) 1.41
Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli. J Biol Chem (1999) 1.39
Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene. Antimicrob Agents Chemother (1998) 1.38
Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J Infect Dis (1988) 1.34
Properties of a variant of Streptococcus mutans altered in its ability to interact with glucans. Infect Immun (1977) 1.32
Collaborative clinical evaluation of the Autobac IDX system for identification of gram-negative bacilli. J Clin Microbiol (1984) 1.30
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev Infect Dis (1988) 1.30
Prevalence of enteric parasites in homosexual patients attending an outpatient clinic. J Clin Microbiol (1986) 1.30
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother (1991) 1.29
Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams. Antimicrob Agents Chemother (1995) 1.25
High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake. Antimicrob Agents Chemother (1986) 1.25
Localization of an amikacin 3'-phosphotransferase in Escherichia coli. J Bacteriol (1981) 1.22
Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Antimicrob Agents Chemother (1994) 1.21
Prevalence and site-pathogen studies of Neisseria meningitidis and N gonorrhoeae in homosexual men. JAMA (1980) 1.18
Use of the API NeIdent system for identification of pathogenic Neisseria spp. and Branhamella catarrhalis. J Clin Microbiol (1984) 1.18
Isolation, characterization, and cloning of a plasmid-borne gene encoding a phosphotransferase that confers high-level amikacin resistance in enteric bacilli. Antimicrob Agents Chemother (1988) 1.13
Experimental infection with parent and L-phase variants of Neisseria meningitidis. J Bacteriol (1968) 1.12
Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa. Rev Infect Dis (1987) 1.11
Serovars and serum resistance of Neisseria gonorrhoeae from disseminated and uncomplicated infections. J Infect Dis (1989) 1.11
Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med (1986) 1.10
A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can J Microbiol (1996) 1.08
Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob Agents Chemother (2001) 1.07
Purification and characterization of aminoglycoside 3'-phosphotransferase type IIa and kinetic comparison with a new mutant enzyme. Antimicrob Agents Chemother (1994) 1.05
Osteomyelitis caused by Rhodococcus equi in a renal transplant recipient. Infection (1988) 1.04
Mechanisms of action of chloroalanyl antibacterial peptides. Identification of the intracellular enzymes inactivated on treatment of Escherichia coli JSR-O with the dipeptide beta Cl-LAla-beta Cl-LAla. J Biol Chem (1986) 1.03
Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase. Antimicrob Agents Chemother (1993) 1.02
Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens. Antimicrob Agents Chemother (1979) 1.01
A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis (1986) 1.01
In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. Antimicrob Agents Chemother (1976) 1.00
Correlation of aminoglycoside resistance with the KmS and Vmax/Km ratios of enzymatic modification of aminoglycosides by 2''-O-nucleotidyltransferase. Antimicrob Agents Chemother (1985) 0.99
Clinical evaluation of the Vitek Neisseria-Haemophilus Identification card. J Clin Microbiol (1987) 0.99
Auxotypes, penicillin susceptibility, and serogroups of Neisseria gonorrhoeae from disseminated and uncomplicated infections. J Infect Dis (1986) 0.97
Aspergillus terreus osteomyelitis. Arch Intern Med (1977) 0.97
Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes. Am J Med (1979) 0.96
Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy. Am Rev Respir Dis (1982) 0.95
Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med (1977) 0.95
Isolation and characterization of a species-specific DNA probe for Candida albicans. Nucleic Acids Res (1991) 0.93
Evaluation of Gonodecten for the presumptive diagnosis of gonococcal urethritis in men. J Clin Microbiol (1985) 0.90
Aminoglycoside ototoxicity. Am J Otolaryngol (1980) 0.89
Single daily dose therapy with aminoglycosides. J Hosp Infect (1991) 0.89
Schooling behavior of tadpoles: a potential indicator of ototoxicity. Pharmacol Biochem Behav (1982) 0.87
Aminoglycoside ototoxicity: a human temporal bone study. Laryngoscope (2001) 0.87
Citrobacter sedlakii meningitis and brain abscess in a premature infant. J Clin Microbiol (1997) 0.86
Isolation of Klebsiella ozaenae from a corneal abscess. Am J Clin Pathol (1985) 0.85
Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours. Am J Hosp Pharm (1985) 0.85
High-level amikacin resistance in Pseudomonas aeruginosa associated with a 3'-phosphotransferase with high affinity for amikacin. Int J Antimicrob Agents (2000) 0.84
Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli. Antimicrob Agents Chemother (1982) 0.84
Aminoglycoside antibiotics in the treatment of otologic infections. Otolaryngol Head Neck Surg (1982) 0.83
Chloroalanyl antibiotic peptides: antagonism of their antimicrobial effects by L-alanine and L-alanyl peptides in gram-negative bacteria. J Med Chem (1986) 0.83
Ganglion cell counts in the cochleae of patients with normal audiograms. Acta Otolaryngol (1985) 0.82
Chloralanyl and propargylglycyl dipeptides. Suicide substrate containing antibacterials. J Med Chem (1983) 0.82
Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS. Ann Pharmacother (1998) 0.81
Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions. J Virol Methods (1991) 0.81
Rare presentation of Streptococcus pneumoniae pneumonia with bacteremia and multiple subcutaneous abscesses. Eur J Clin Microbiol Infect Dis (2002) 0.81
Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J Infect Dis (1987) 0.80
Lack of accumulation of exogenous adenylyl dihydrostreptomycin by whole cells or spheroplasts of Escherichia coli. Antimicrob Agents Chemother (1985) 0.79
Case/control study of the role of splenectomy in chronic lymphocytic leukemia. J Clin Oncol (1997) 0.79
Enhanced glucosyltransferase activity in penicillin-treated cultures of Streptococcus mutans. Infect Immun (1978) 0.79
Production of extracellular and cell-associated glucosyltransferase activity by Streptococcus mutans during growth on various carbon sources. Infect Immun (1978) 0.78
Biphasic systemic anaphylactic reaction: three illustrative cases. Ann Allergy (1984) 0.78